Day One Biopharmaceuticals
Day One Biopharmaceuticals is a commercial-stage biopharma focused on pediatric oncology, addressing unmet needs by developing targeted therapies.
Company facts
- Founded
- 2018
- Employees
- 200
- Headquarters
- United States
- Type
- Small Business
About
Day One Biopharmaceuticals is a commercial-stage biopharma focused on pediatric oncology, addressing unmet needs by developing targeted therapies. They partner with clinicians, families, and scientists to identify and advance novel treatments, with a pipeline that includes tovorafenib (OJEMDA™), DAY301, and the recently acquired Emi‑Le ADC targeting B7‑H4 for adenoid cystic carcinoma. Their approach reimagines drug development from the first diagnosis, emphasizing early intervention and precision medicine. The company’s collaborative culture fosters innovation and patient‑centered research, positioning it as a distinctive player in oncology and translational medicine.